#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastrointestinal disorder Pulmonary tuberculosis Mitochondrial encephalomyopathy Leukoencephalopathy Osteosarcoma recurrent Anti-myelin-associated glycoprotein antibodies positive Guillain-Barre syndrome Mantle cell lymphoma stage III Post transplant lymphoproliferative disorder Mucous membrane pemphigoid Neurofibroma Metastatic malignant melanoma Deafness bilateral Liver transplant rejection Primary hyperoxaluria More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Life with Disease Alport’s syndrome – Basic Information Extranodal marginal zone B-cell lymphoma (MALT type) Nodal marginal zone B-cell lymphoma – Life with Disease Toxic epidermal necrolysis – Life with Disease Hyperoxaluria – Diagnostics Glomerulonephritis rapidly progressive Carcinoid syndrome Hyperoxaluria Progressive supranuclear palsy – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Infliximab Pimozide Ranolazine Envudeucitinib Oxaliplatin Vinorelbine ENSIFENTRINE Cariprazine Hydrochloride GSKVX000000048110 Heparin Sodium Cetrimide Ziftomenib Etidronate Disodium Cinnarizine Rupatadine Avb-101 Zoledronic Acid Monohydrate Regorafenib VOXVOGANAN Caspofungin More therapies…

    Learn about Your Condition

    Agitation Iron deficiency Mantle cell lymphoma stage IV Oedema peripheral Myositis Angiosarcoma recurrent Left ventricular failure Colitis ulcerative Malignant melanoma of eyelid Spinal cord injury Ejection fraction normal Endometrial cancer stage I Cytomegalovirus infection Proteinuria Cardiac valve disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neuroblastoma

  • Study on the Safety of Lutetium (177Lu) Oxodotreotide with Arginine and Lysine in Children with Refractory or Recurrent Neuroblastoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • Arginine Hydrochloride
    • Lysine Hydrochloride
    • Lutetium (177Lu) Oxodotreotide
    France

  • Study of LY3295668 Erbumine for Patients with Relapsed or Refractory Neuroblastoma

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • (2R,4R)-1-(3-Chloro-2-Fluorobenzyl)-4-((3-Fluoro-6-((5-Methyl-1H-Pyrazol-3-Yl)Amino)Pyridin-2-Yl)Methyl)-2-Methylpiperidine-4-Carboxylic Acid
    Spain

  • Study of Palbociclib with Drug Combinations for Children and Young Adults with Recurrent or Refractory Neuroblastoma and Ewing Sarcoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    • Ewing’s sarcoma
    Investigated Drugs:
    • Cyclophosphamide Monohydrate
    • Irinotecan Hydrochloride Trihydrate
    • Topotecan
    Czechia France Germany Slovakia Sweden

  • Study on Bevacizumab with Temozolomide and Irinotecan for Children with Relapsed or Refractory Neuroblastoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • Dinutuximab Beta
    • Topotecan
    • Bevacizumab
    Belgium Denmark France The Netherlands Spain

  • Study on Ribociclib, Topotecan, and Temozolomide for Children and Young Adults (12 months – 21 years) with Relapsed or Refractory Neuroblastoma and Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Medulloblastoma
    • Rhabdoid tumour
    • Neuroblastoma
    Investigated Drugs:
    • Ribociclib
    • Temozolomide
    • Topotecan Hydrochloride
    Czechia Denmark France Germany Hungary Italy +1

  • Study on Dinutuximab Beta and Chemotherapy for Patients with Neuroblastoma Resistant to Standard Treatment or with Relapsed Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • Dinutuximab Beta
    Poland
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!